Skip to content
2000
Volume 25, Issue 15
  • ISSN: 1389-5575
  • E-ISSN: 1875-5607

Abstract

Arthritis has become a global public health issue due to its diverse risk factors and high prevalence. Therefore, there is a demand for more effective drugs to improve these situations. Triterpenoids have attracted the interest of researchers because of their broad spectrum of biological activities and pharmacological effects. The aim of this review is to provide an updated overview of the potential of triterpenoids and of their derivatives as therapeutic agents against Rheumatoid Arthritis (RA) and Osteoarthritis (OA), based on their anti-inflammatory and immunomodulatory properties. This review discusses the chemical and pharmacological properties of triterpenoids and their derivatives, focusing on the different mechanisms by which this class of compounds achieves therapeutic benefits in arthritis. The conclusions indicate that triterpenoids and their derivatives have a favorable potential therapeutic effect on arthritis.

© 2025 Bentham Science Publishers
Loading

Article metrics loading...

/content/journals/mrmc/10.2174/0113895575389522250825063702
2025-08-29
2026-02-27

  • From This Site

    /content/journals/mrmc/10.2174/0113895575389522250825063702
    dcterms_title,dcterms_subject,pub_keyword
    -contentType:Contributor -contentType:Concept -contentType:Institution
    10
    5
Loading full text...

Full text loading...

References

  1. FaustinoC. PinheiroL. DuarteN. Triterpenes as potential drug candidates for rheumatoid arthritis treatment.Life2023137151410.3390/life1307151437511889
     [Google Scholar]
  2. YinQ. XiangL. HanX. ZhangY. LyuR. YuanL. ChenS. The evolutionary advantage of artemisinin production by Artemisia annua.Trends Plant Sci.202530221322610.1016/j.tplants.2024.09.00639362811
     [Google Scholar]
  3. ChengL. JiT. ZhangM. FangB. Recent advances in squalene: Biological activities, sources, extraction, and delivery systems.Trends Food Sci. Technol.202414610439210.1016/j.tifs.2024.104392
     [Google Scholar]
  4. HaqueM.A. NathN.D. JohnstonT.V. HarunaS. AhnJ. OvissipourR. KuS. Harnessing biotechnology for penicillin production: Opportunities and environmental considerations.Sci. Total Environ.202494617423610.1016/j.scitotenv.2024.17423638942308
     [Google Scholar]
  5. ZhaoY. MiettinenK. KampranisS.C. Celastrol: A century-long journey from the isolation to the biotechnological production and the development of an antiobesity drug.Curr. Opin. Plant Biol.20248110261510.1016/j.pbi.2024.10261539128271
     [Google Scholar]
  6. ZhangJ. JiangP. WangS. LiM. HaoZ. GuanW. PanJ. WuJ. ZhangY. LiH. ChenL. YangB. LiuY. Recent advances in the natural product analogues for the treatment of neurodegenerative diseases.Bioorg. Chem.202415310781910.1016/j.bioorg.2024.10781939276492
     [Google Scholar]
  7. WangM. LiF. WangZ. LvL. LiuW. Research progress of natural product-conjugated platinum and gold complexes as potential antitumor agents.Eur. J. Med. Chem.202428011695610.1016/j.ejmech.2024.11695639413444
     [Google Scholar]
  8. LiY. WangJ. LiL. SongW. LiM. HuaX. WangY. YuanJ. XueZ. Natural products of pentacyclic triterpenoids: from discovery to heterologous biosynthesis.Nat. Prod. Rep.20234081303135310.1039/D2NP00063F36454108
     [Google Scholar]
  9. LuJ. YanS. XueZ. Biosynthesis and functions of triterpenoids in cereals.J. Adv. Res.20257115517110.1016/j.jare.2024.05.02138788922
     [Google Scholar]
  10. OsbournA. GossR.J.M. FieldR.A. The saponins – polar isoprenoids with important and diverse biological activities.Nat. Prod. Rep.20112871261126810.1039/c1np00015b21584304
     [Google Scholar]
  11. WangS. MengD. FengM. LiC. WangY. Efficient plant triterpenoids synthesis in Saccharomyces cerevisiae: From mechanisms to engineering strategies.ACS Synth. Biol.20241341059107610.1021/acssynbio.4c0006138546129
     [Google Scholar]
  12. MathurA. SinghA. HussainY. MishraA. MeenaA. MishraN. LuqmanS. Regulating pri/pre-microRNA up/down expressed in cancer proliferation, angiogenesis and metastasis using selected potent triterpenoids.Int. J. Biol. Macromol.2024257Pt 112794510.1016/j.ijbiomac.2023.12794537951434
     [Google Scholar]
  13. MuM. ZhouW. ArcotY. Cisneros-ZevallosL. AkbulutM. Edible superhydrophobic coating derived from triterpenoid maslinic acid for bacterial antifouling and enhanced fresh produce food safety.Food Packag. Shelf Life20244310129010.1016/j.fpsl.2024.101290
     [Google Scholar]
  14. LiY. HaoN. YeS. HuZ. ZhaoL. QiY. TianX. New triterpenoid saponins from Clematis lasiandra and their mode of action against pea aphids Acyrthosiphon pisum.Ind. Crops Prod.202218711551710.1016/j.indcrop.2022.115517
     [Google Scholar]
  15. ChenR. LiY. ZhangN. ZhangL. ZhangP. WuT. Anti-inflammatory oleanane triterpenoids with mono-, di-, and tri-palmitoyl chains from the stamen of Nelumbo nucifera Gaertn.Ind. Crops Prod.202421611869810.1016/j.indcrop.2024.118698
     [Google Scholar]
  16. NagA. DasguptaA. SenguptaS. LaiT.K. AcharyaK. An in-silico pharmacophore-based molecular docking study to evaluate the inhibitory potentials of novel fungal triterpenoid Astrakurkurone analogues against a hypothetical mutated main protease of SARS-CoV-2 virus.Comput. Biol. Med.202315210643310.1016/j.compbiomed.2022.10643336565483
     [Google Scholar]
  17. XiaR.F. WeiY.R. ZhangC.Q. HuangY. ChenM.S. YuanX.Y. ZhaH.J. LaiK.D. XiaX. WanL.S. Structurally diverse triterpenoids with antibacterial activities from Euphorbia humifusa.Bioorg. Chem.202415310791510.1016/j.bioorg.2024.10791539471543
     [Google Scholar]
  18. LeeJ. LimJ.H. JungG.Y. KangJ. JoI. KangK. KimJ.H. KimB.S. YangH. Triterpenoid saponins from Camellia sinensis roots with cytotoxic and immunomodulatory effects.Phytochemistry202321211368810.1016/j.phytochem.2023.11368837121294
     [Google Scholar]
  19. CoghiP. NgJ.P.L. KadiogluO. LawB.Y.K. QiuA.C. SaeedM.E.M. ChenX. IpC.K. EfferthT. LiuL. WongV.K.W. Synthesis, computational docking and biological evaluation of celastrol derivatives as dual inhibitors of SERCA and P-glycoprotein in cancer therapy.Eur. J. Med. Chem.202122411367610.1016/j.ejmech.2021.11367634256125
     [Google Scholar]
  20. XieY. KuanH. WeiQ. GianoncelliA. RibaudoG. CoghiP. (2R,4aS,6aS,12bR,14aS,14bR)10-Hydroxy-N-(4-((6-methoxyqui-nolin-8-yl)amino)pentyl)-2,4a,6a,9,12b,14a-hexamethyl-11-oxo-1,2,3,4,4a,5,6,6a,11,12b,13,14,14a,14b-tetradecahydropicene-2-carboxamide.Molbank202320233M171610.3390/M1716
     [Google Scholar]
  21. NgJ.P.L. HanY. YangL.J. BirkholtzL.M. CoertzenD. WongH.N. HaynesR.K. CoghiP. WongV.K.W. Antimalarial and antitumour activities of the steroidal quinone-methide celastrol and its combinations with artemiside, artemisone and methylene blue.Front. Pharmacol.20221398874810.3389/fphar.2022.98874836120293
     [Google Scholar]
  22. TakeuchiR. OgiharaK. FujimotoJ. SatoK. MaseN. YoshimuraK. HaradaS. NarumiT. Design, synthesis, and bio-evaluation of novel triterpenoid derivatives as anti-HIV-1 compounds.Bioorg. Med. Chem. Lett.20226912876810.1016/j.bmcl.2022.12876835513221
     [Google Scholar]
  23. WangM.C. KongW.Z. YangG.C. WangC.H. ZhangL.H. GaoJ.M. ZhangX.Y. Structure, anti-inflammatory and anti-bacterial activities of novel pentacyclic triterpenoids and other constituents from the leaves of Pittosporum elevaticostatum.Fitoterapia202417710614210.1016/j.fitote.2024.10614239067487
     [Google Scholar]
  24. HuangY. HouP. PanL.W. LiangX.Q. RenC.Y. PengL.T. GanC.Q. YangR.Y. XuW.F. LiJ. ZhangY.J. Oleanane-type triterpenoids from Sabia limoniacea and their anti-inflammatory activities.Bioorg. Chem.202415110768310.1016/j.bioorg.2024.10768339121595
     [Google Scholar]
  25. JohnR. DalalB. ShankarkumarA. DevarajanP.V. Innovative Betulin Nanosuspension exhibits enhanced anticancer activity in a triple negative breast cancer cell line and zebrafish angiogenesis model.Int. J. Pharm.202160012051110.1016/j.ijpharm.2021.12051133766639
     [Google Scholar]
  26. LiN. XuM. ZhangL. LeiZ. ChenC. ZhangT. ChenL. SunJ. Discovery of novel celastrol–imidazole derivatives with anticancer activity in vitro and in vivo.J. Med. Chem.20226564578458910.1021/acs.jmedchem.1c0129335238566
     [Google Scholar]
  27. MohapatraP. MadhulikaS. BeheraS. SinghP. SaP. PrasadP. SwainR.K. SahooS.K. Nimbolide-based nanomedicine inhibits breast cancer stem-like cells by epigenetic reprogramming of DNMTs-SFRP1-Wnt/β-catenin signaling axis.Mol. Ther. Nucleic Acids20233410203110.1016/j.omtn.2023.10203137771911
     [Google Scholar]
  28. WangW.Y. WuW.Y. LiA.L. LiuQ.S. SunY. GuW. Synthesis, anticancer evaluation and mechanism studies of novel indolequinone derivatives of ursolic acid.Bioorg. Chem.202110910470510.1016/j.bioorg.2021.10470533618252
     [Google Scholar]
  29. ZhaoJ. XuJ. ZhangZ. ShaoZ. MengD. Barrigenol-like triterpenoid saponins from the husks of Xanthoceras sorbifolia bunge and their anti-inflammatory activity by inhibiting COX-2 and iNOS expression.Phytochemistry202220411343010.1016/j.phytochem.2022.11343036108987
     [Google Scholar]
  30. YaoY. FanS. FanY. ShenX. ChaiX. PiJ. HuangX. ShaoY. ZhouZ. ZhaoY. JinH. Intratracheal delivery of macrophage targeted Celastrol-loaded PLGA nanoparticles for enhanced anti-inflammatory efficacy in acute lung injury mice.Eur. J. Pharm. Biopharm.202420411451110.1016/j.ejpb.2024.11451139307441
     [Google Scholar]
  31. El-SherbinyM. EisaN.H. Abo El-MagdN.F. ElsherbinyN.M. SaidE. KhodirA.E. Anti-inflammatory/anti-apoptotic impact of betulin attenuates experimentally induced ulcerative colitis: An insight into TLR4/NF-kB/caspase signalling modulation.Environ. Toxicol. Pharmacol.20218810375010.1016/j.etap.2021.10375034597787
     [Google Scholar]
  32. ZhaoJ. ZhengH. SuiZ. JingF. QuanX. ZhaoW. LiuG. Ursolic acid exhibits anti-inflammatory effects through blocking TLR4-MyD88 pathway mediated by autophagy.Cytokine201912315472610.1016/j.cyto.2019.05.01331302461
     [Google Scholar]
  33. YangM. MaoL. YangX. XuX. TangC. WeiW. ChenJ. Ginsenoside compound K exerts anti-inflammatory effects through transcriptional activation and transcriptional inhibition of glucocorticoid receptor in rheumatoid arthritis fibroblast-like synoviocytes.Int. Immunopharmacol2023125Pt A11108010.1016/j.intimp.2023.11108037883815
     [Google Scholar]
  34. WangZ. ZhangH. QiC. GuoH. JiaoX. YanJ. WangY. LiQ. ZhaoM. GuoX. WanB. LiX. Ursolic acid ameliorates DNCB-induced atopic dermatitis-like symptoms in mice by regulating TLR4/NF-κB and Nrf2/HO-1 signaling pathways.Int. Immunopharmacol.202311811007910.1016/j.intimp.2023.11007936996741
     [Google Scholar]
  35. LuX. WangY. GuoW. ZhangZ. HuX. NieT. YangX. LiC. WangX. LiX. LuY. LiG. ZhangY. SunL. PangJ. YouX. Antibacterial activity of an ftsz inhibitor celastrol and its synergistic effect with vancomycin against enterococci In Vitro and In Vivo.Microbiol. Spectr.2023111e03699e2210.1128/spectrum.03699‑2236622182
     [Google Scholar]
  36. SunY. LiX. WangY. ShangX. HuangW. AngS. LiD. WongW.L. HongW.D. ZhangK. WuP. In vitro and in vivo evaluation of novel ursolic acid derivatives as potential antibacterial agents against methicillin-resistant Staphylococcus aureus (MRSA).Bioorg. Chem.202515410798610.1016/j.bioorg.2024.10798639615282
     [Google Scholar]
  37. ZhangJ. SunY. WangY. LuM. HeJ. LiuJ. ChenQ. ZhangX. ZhouF. WangG. SunX. Non-antibiotic agent ginsenoside 20(S)-Rh2 enhanced the antibacterial effects of ciprofloxacin in vitro and in vivo as a potential NorA inhibitor.Eur. J. Pharmacol.201474027728410.1016/j.ejphar.2014.07.02025054686
     [Google Scholar]
  38. PooladandaV. ThatikondaS. SunnapuO. TiwaryS. VemulaP.K. TalluriM.V.N.K. GoduguC. iRGD conjugated nimbolide liposomes protect against endotoxin induced acute respiratory distress syndrome.Nanomedicine20213310235110.1016/j.nano.2020.10235133418136
     [Google Scholar]
  39. KangS. SongM.J. MinH. Antiviral activity of ginsenoside Rg3 isomers against gammaherpesvirus through inhibition of p38- and JNK-associated pathways.J. Funct. Foods20184021922810.1016/j.jff.2017.11.011
     [Google Scholar]
  40. YuJ.S. TsengC.K. LinC.K. HsuY.C. WuY.H. HsiehC.L. LeeJ.C. Celastrol inhibits dengue virus replication via up-regulating type I interferon and downstream interferon-stimulated responses.Antiviral Res.2017137495710.1016/j.antiviral.2016.11.01027847245
     [Google Scholar]
  41. ZhangW. JiangH. YangJ. JinM. DuY. SunQ. CaoL. XuH. Safety assessment and antioxidant evaluation of betulin by LC-MS combined with free radical assays.Anal. Biochem.201958711346010.1016/j.ab.2019.11346031563442
     [Google Scholar]
  42. DivyaT. DineshbabuV. SoumyakrishnanS. SureshkumarA. SudhandiranG. Celastrol enhances Nrf2 mediated antioxidant enzymes and exhibits anti-fibrotic effect through regulation of collagen production against bleomycin-induced pulmonary fibrosis.Chem. Biol. Interact.2016246526210.1016/j.cbi.2016.01.00626768587
     [Google Scholar]
  43. SamyB.A. RamanK. VelayuthamS. SenthilkumarN. ThirumalaivasanN. KanagarajK. PothuR. BoddulaR. RadwanA.B. Al-QahtaniN. Natural product extract fractions as potential arthritis treatments: A detailed analysis using in-silico, in-vivo, and in-vitro methods.Int. Immunopharmacol.202514411359510.1016/j.intimp.2024.11359539580856
     [Google Scholar]
  44. MisraD.P. Clinical manifestations of rheumatoid arthritis, including comorbidities, complications, and long-term follow-up.Best Pract. Res. Clin. Rheumatol.202539110202010.1016/j.berh.2024.10202039489658
     [Google Scholar]
  45. SharmaS.D. LeungS.H. ViatteS. Genetics of rheumatoid arthritis.Best Pract. Res. Clin. Rheumatol.202438410196810.1016/j.berh.2024.10196838955657
     [Google Scholar]
  46. ZengL. ShiY. SubatijangP. ZhangL. GaoJ. SunR. JiangK. Global research trends and hotspots in rheumatoid arthritis joint replacement:Bibliometric analysis and visualization study.J. Orthop.202561728410.1016/j.jor.2024.09.01739430126
     [Google Scholar]
  47. JangS. KwonE.J. LeeJ.J. Rheumatoid arthritis: Pathogenic roles of diverse immune cells.Int. J. Mol. Sci.202223290510.3390/ijms2302090535055087
     [Google Scholar]
  48. GravalleseE.M. FiresteinG.S. Rheumatoid arthritis — Common origins, divergent mechanisms.N. Engl. J. Med.2023388652954210.1056/NEJMra210372636780677
     [Google Scholar]
  49. Martel-PelletierJ. BarrA.J. CicuttiniF.M. ConaghanP.G. CooperC. GoldringM.B. GoldringS.R. JonesG. TeichtahlA.J. PelletierJ.P. Osteoarthritis. Nat. Rev. Dis. Primers2016211607210.1038/nrdp.2016.7227734845
     [Google Scholar]
  50. Glyn-JonesS. PalmerA.J.R. AgricolaR. PriceA.J. VincentT.L. WeinansH. CarrA.J. Osteoarthritis. Lancet2015386999137638710.1016/S0140‑6736(14)60802‑325748615
     [Google Scholar]
  51. JiangY. Osteoarthritis year in review 2021: biology.Osteoarthritis Cartilage202230220721510.1016/j.joca.2021.11.00934801671
     [Google Scholar]
  52. AbramoffB. CalderaF.E. Osteoarthritis. Med. Clin. North Am2020104229331110.1016/j.mcna.2019.10.00732035570
     [Google Scholar]
  53. KnightsA.J. ReddingS.J. MaerzT. Inflammation in osteoarthritis: the latest progress and ongoing challenges.Curr. Opin. Rheumatol.202335212813410.1097/BOR.000000000000092336695054
     [Google Scholar]
  54. ZhaoZ.X. ZouQ.Y. MaY.H. Morris-NatschkeS.L. LiX.Y. ShiL.C. MaG.X. XuX.D. YangM.H. ZhaoZ.J. LiY.X. XueJ. ChenC.H. WuH.F. Recent progress on triterpenoid derivatives and their anticancer potential.Phytochemistry202522911425710.1016/j.phytochem.2024.11425739209239
     [Google Scholar]
  55. VenetsanopoulouA.I. AlamanosY. VoulgariP.V. DrososA.A. Epidemiology of rheumatoid arthritis: Genetic and environmental influences.Expert Rev. Clin. Immunol.202218992393110.1080/1744666X.2022.210697035904251
     [Google Scholar]
  56. van der WoudeD. van der Helm-van MilA.H.M. Update on the epidemiology, risk factors, and disease outcomes of rheumatoid arthritis.Best Pract. Res. Clin. Rheumatol.201832217418710.1016/j.berh.2018.10.00530527425
     [Google Scholar]
  57. FidlerL. WiddifieldJ. FisherJ.H. ShaperaS. GershonA.S. Rheumatoid arthritis associated interstitial lung disease: Trends in epidemiology and mortality in Ontario from 2000 to 2018.Respir. Med.20231310728210.1016/j.rmed.2023.10728237187431
     [Google Scholar]
  58. BerenbaumF. WallaceI.J. LiebermanD.E. FelsonD.T. Modern-day environmental factors in the pathogenesis of osteoarthritis.Nat. Rev. Rheumatol.2018141167468110.1038/s41584‑018‑0073‑x30209413
     [Google Scholar]
  59. CourtiesA. KoukiI. SolimanN. MathieuS. SellamJ. Osteoarthritis year in review 2024: Epidemiology and therapy.Osteoarthritis Cartilage202432111397140410.1016/j.joca.2024.07.01439103081
     [Google Scholar]
  60. AllenK.D. ThomaL.M. GolightlyY.M. Epidemiology of osteoarthritis.Osteoarthritis Cartilage202230218419510.1016/j.joca.2021.04.02034534661
     [Google Scholar]
  61. SrivastavaS. RasoolM. Genetics, epigenetics and autoimmunity constitute a Bermuda triangle for the pathogenesis of rheumatoid arthritis.Life Sci.202435710.1016/j.lfs.2024.123075
     [Google Scholar]
  62. SchererH.U. HäuplT. BurmesterG.R. The etiology of rheumatoid arthritis.J. Autoimmun.202011010240010.1016/j.jaut.2019.10240031980337
     [Google Scholar]
  63. DieppeP.A. LohmanderL.S. Pathogenesis and management of pain in osteoarthritis.Lancet2005365946396597310.1016/S0140‑6736(05)71086‑215766999
     [Google Scholar]
  64. GriffinT.M. HuebnerJ.L. KrausV.B. GuilakF. Extreme obesity due to impaired leptin signaling in mice does not cause knee osteoarthritis.Arthritis Rheum.200960102935294410.1002/art.2485419790050
     [Google Scholar]
  65. FranciscoV. PérezT. PinoJ. LópezV. FrancoE. AlonsoA. Gonzalez-GayM.A. MeraA. LagoF. GómezR. GualilloO. Biomechanics, obesity, and osteoarthritis. The role of adipokines: When the levee breaks.J. Orthop. Res.201836259460410.1002/jor.2378829080354
     [Google Scholar]
  66. XiaB. Di Chen; Zhang, J.; Hu, S.; Jin, H.; Tong, P. Osteoarthritis pathogenesis: A review of molecular mechanisms.Calcif. Tissue Int.201495649550510.1007/s00223‑014‑9917‑925311420
     [Google Scholar]
  67. BaigM.M.F.A. KwanC.H. WuH. ChairS.Y. The etiology, pathogenesis, treatment, and development of transdermal drug delivery systems for rheumatoid arthritis.RSC Pharmaceutics20241459260710.1039/D4PM00085D
     [Google Scholar]
  68. GuoH. LiL. LiuB. LuP. CaoZ. JiX. LiL. OuyangG. NieZ. LyuA. LuC. Inappropriate treatment response to DMARDs: A pathway to difficult-to-treat rheumatoid arthritis.Int. Immunopharmacol.202312211065510.1016/j.intimp.2023.11065537481847
     [Google Scholar]
  69. MitsuboshiS. Risk of haematological events and preventive effect of folic acid in methotrexate users with chronic kidney disease and rheumatoid arthritis: Analysis of the Japanese Adverse Drug Event Report database.Br. J. Clin. Pharmacol.20218752286228910.1111/bcp.1464133179261
     [Google Scholar]
  70. ZewailM.B. AsaadG.F. ShabanaM.E. ElbokhomyA.S. ElbadryA.M.M. RiadP.Y. SalamaG.A. El-DakrouryW.A. PEGylated lipid polymeric nanoparticles for management of rheumatoid arthritis.J. Drug Deliv. Sci. Technol.202410110624210.1016/j.jddst.2024.106242
     [Google Scholar]
  71. Di FrancescoM. FragassiA. PannuzzoM. FerreiraM. BrahmachariS. DecuzziP. Management of osteoarthritis: From drug molecules to nano/ micromedicines.Wiley Interdiscip. Rev. Nanomed. Nanobiotechnol.2022143e178010.1002/wnan.178035253405
     [Google Scholar]
  72. SteinmeyerJ. BockF. StöveJ. JeroschJ. FlechtenmacherJ. Pharmacological treatment of knee osteoarthritis: Special considerations of the new German guideline.Orthop. Rev.2018104778210.4081/or.2018.778230662685
     [Google Scholar]
  73. BátaiI.Z. SárC.P. HorváthÁ. BorbélyÉ. BölcskeiK. KeményÁ. SándorZ. NemesB. HelyesZ. PerkeczA. MócsaiA. PozsgaiG. PintérE. TRPA1 ion channel determines beneficial and detrimental effects of GYY4137 in murine serum-transfer arthritis.Front. Pharmacol.20191096410.3389/fphar.2019.0096431551776
     [Google Scholar]
  74. Mäki-OpasI. HämäläinenM. MoilanenL.J. HaavikkoR. AhonenT.J. AlakurttiS. MoreiraV.M. MurakiK. Yli-KauhaluomaJ. MoilanenE. Pyrazine-fused triterpenoids block the TRPA1 ion channel in vitro and inhibit TRPA1-mediated acute inflammation in vivo.ACS Chem. Neurosci.20191062848285710.1021/acschemneuro.9b0008331034197
     [Google Scholar]
  75. MoilanenL.J. HämäläinenM. NummenmaaE. IlmarinenP. VuolteenahoK. NieminenR.M. LehtimäkiL. MoilanenE. Monosodium iodoacetate-induced inflammation and joint pain are reduced in TRPA1 deficient mice – potential role of TRPA1 in osteoarthritis.Osteoarthritis Cartilage201523112017202610.1016/j.joca.2015.09.00826521748
     [Google Scholar]
  76. HuiminD. HuiC. GuoweiS. ShouyunX. JunyangP. JunchengW. Protective effect of betulinic acid on Freund’s complete adjuvant‐induced arthritis in rats.J. Biochem. Mol. Toxicol.2019339e2237310.1002/jbt.2237331364231
     [Google Scholar]
  77. XuJ. LiZ. LuoJ. YangF. LiuT. LiuM. QiuW.W. TangJ. Synthesis and biological evaluation of heterocyclic ring-fused betulinic acid derivatives as novel inhibitors of osteoclast differentiation and bone resorption.J. Med. Chem.20125573122313410.1021/jm201540h22435650
     [Google Scholar]
  78. GuoY. XiaoY. ColucciniC. CoghiP. ((1R,3aS,5aR,5bR,7aR,9S,11aR,11bR,13aR,13bR)-9-Acetoxy-5a,5b,8,8,11a-pentamethyl-1-(prop-1-en-2-yl)icosahydro-3aH-cyclopenta[a]chrysen-3a-yl)methyl 2-Bromo-3-methylbenzoate.Molbank202520251M197110.3390/M1971
     [Google Scholar]
  79. WangJ. WeiW. ZhangX. CaoS. HuB. YeY. JiangM. WangT. ZuoJ. HeS. YangC. Synthesis and biological evaluation of C-17-amino-substituted pyrazole-fused betulinic acid derivatives as novel agents for osteoarthritis treatment.J. Med. Chem.20216418136761369210.1021/acs.jmedchem.1c0101934491054
     [Google Scholar]
  80. NummenmaaE. HämäläinenM. MoilanenL.J. PaukkeriE.L. NieminenR.M. MoilanenT. VuolteenahoK. MoilanenE. Transient receptor potential ankyrin 1 (TRPA1) is functionally expressed in primary human osteoarthritic chondrocytes.Arthritis Res. Ther.201618118510.1186/s13075‑016‑1080‑427515912
     [Google Scholar]
  81. de Seabra Rodrigues DiasI.R. MokS.W.F. Gordillo-MartínezF. KhanI. HsiaoW.W.L. LawB.Y.K. WongV.K.W. LiuL. The calcium-induced regulation in the molecular and transcriptional circuitry of human inflammatory response and autoimmunity.Front. Pharmacol.2018896210.3389/fphar.2017.0096229358919
     [Google Scholar]
  82. WongV.K.W. QiuC. XuS.W. LawB.Y.K. ZengW. WangH. MichelangeliF. DiasI.R.D.S.R. QuY.Q. ChanT.W. HanY. ZhangN. MokS.W.F. ChenX. YuL. PanH. HamdounS. EfferthT. YuW.J. ZhangW. LiZ. XieY. LuoR. JiangQ. LiuL. Ca2+ signalling plays a role in celastrol‐mediated suppression of synovial fibroblasts of rheumatoid arthritis patients and experimental arthritis in rats.Br. J. Pharmacol.2019176162922294410.1111/bph.1471831124139
     [Google Scholar]
  83. YangJ. LiuJ. LiJ. JingM. ZhangL. SunM. WangQ. SunH. HouG. WangC. XinW. Celastrol inhibits rheumatoid arthritis by inducing autophagy via inhibition of the PI3K/AKT/mTOR signaling pathway.Int. Immunopharmacol.202211210924110.1016/j.intimp.2022.10924136116150
     [Google Scholar]
  84. YinL. FanY. ZhongX. MengX. HeZ. HongZ. ChenJ. ZhangQ. KongM. WangJ. TongY. BiQ. The therapeutic potential of pristimerin in osteoarthritis: Mechanistic insights from in vitro and in vivo studies.Drug Des. Devel. Ther.2024185445545910.2147/DDDT.S49038839628956
     [Google Scholar]
  85. Kumar SinghP. KashyapA. SilakariO. Exploration of the therapeutic aspects of Lck: A kinase target in inflammatory mediated pathological conditions.Biomed. Pharmacother.20181081565157110.1016/j.biopha.2018.10.00230372858
     [Google Scholar]
  86. HeQ.W. FengJ.H. HuX.L. LongH. HuangX.F. JiangZ.Z. ZhangX.Q. YeW.C. WangH. Synthesis and biological evaluation of celastrol derivatives as potential immunosuppressive agents.J. Nat. Prod.20208392578258610.1021/acs.jnatprod.0c0006732822186
     [Google Scholar]
  87. LimamiY. PinonA. WahnouH. OudghiriM. LiagreB. SimonA. DuvalR.E. Ursolic Acid’s alluring journey: One triterpenoid vs. cancer hallmarks.Molecules20232823789710.3390/molecules2823789738067626
     [Google Scholar]
  88. HuangL. HuS. ShaoM. WuX. ZhangJ. CaoG. Combined Cornus officinalis and Paeonia lactiflora pall therapy alleviates rheumatoid arthritis by regulating synovial apoptosis via ampk-mediated mitochondrial fission.Front. Pharmacol.20211263900910.3389/fphar.2021.63900933897428
     [Google Scholar]
  89. ZahranE.M. MohamadS.A. ElsayedM.M. HishamM. MaherS.A. AbdelmohsenU.R. ElrehanyM. DesoukeyS.Y. KamelM.S. Ursolic acid inhibits NF-κB signaling and attenuates MMP-9/TIMP-1 in progressive osteoarthritis: a network pharmacology-based analysis.RSC Advances20241426182961831010.1039/D4RA02780A38863821
     [Google Scholar]
  90. LvJ. SharmaA. ZhangT. WuY. DingX. Pharmacological review on asiatic acid and its derivatives: A potential compound.SLAS Technol.201823211112710.1177/247263031775184029361877
     [Google Scholar]
  91. SunM. WangQ. HuangJ. SunQ. YuQ. LiuX. LiuZ. Asiatic acid induces ferroptosis of RA-FLS via the Nrf2/HMOX1 pathway to relieve inflammation in rheumatoid arthritis.Int. Immunopharmacol.202413711239410.1016/j.intimp.2024.11239438852517
     [Google Scholar]
  92. NaginiS. NivethaR. PalrasuM. MishraR. Nimbolide, a Neem Limonoid, Is a promising candidate for the anticancer drug arsenal.J. Med. Chem.20216473560357710.1021/acs.jmedchem.0c0223933739088
     [Google Scholar]
  93. AnchiP. SwamyV. GoduguC. Nimbolide exerts protective effects in complete Freund’s adjuvant induced inflammatory arthritis via abrogation of STAT-3/NF-κB/Notch-1 signaling.Life Sci.202126611891110.1016/j.lfs.2020.11891133333049
     [Google Scholar]
  94. IsrarM. NaseemN. AkhtarT. AftabU. ZafarM.S. FaheemM.A. ShahzadM. Nimbolide attenuates complete Freund’s adjuvant induced arthritis through expression regulation of toll‐like receptors signaling pathway.Phytother. Res.202337390391210.1002/ptr.767236437579
     [Google Scholar]
  95. AnchiP. PandaB. MahajanR.B. GoduguC. Co-treatment of Nimbolide augmented the anti-arthritic effects of methotrexate while protecting against organ toxicities.Life Sci.202229512037210.1016/j.lfs.2022.12037235143824
     [Google Scholar]
  96. YangY. JianY. LiuY. IsmailM. XieQ. YuH. WangB. LiB. PengC. LiuB. ManR. WangW. triterpenoids from kadsura coccinea with their anti-inflammatory and inhibited proliferation of rheumatoid arthritis-fibroblastoid synovial cells activities.Front Chem.2021980887010.3389/fchem.2021.80887034957056
     [Google Scholar]
  97. YangY. JianY. LiuY. XieQ. YuH. WangB. LiB. PengC. WangW. HeilaohuacidG. Heilaohuacid G, a new triterpenoid from Kadsura coccinea inhibits proliferation, induces apoptosis, and ameliorates inflammation in RA‐FLS and RAW 264.7 cells via suppressing NF ‐􄙶B pathway.Phytother. Res.202236103900391010.1002/ptr.752736104304
     [Google Scholar]
  98. AhmadM.F. WahabS. AhmadF.A. AshrafS.A. AbullaisS.S. SaadH.H. Ganoderma lucidum: A potential pleiotropic approach of ganoderic acids in health reinforcement and factors influencing their production.Fungal Biol. Rev.20223910012510.1016/j.fbr.2021.12.003
     [Google Scholar]
  99. CaoT. TangC. XueL. CuiM. WangD. Protective effect of Ganoderic acid A on adjuvant-induced arthritis.Immunol. Lett.20202261610.1016/j.imlet.2020.06.01032565114
     [Google Scholar]
  100. WuW. SongK. ChenG. LiuN. CaoT. Ganoderic acid A improves osteoarthritis by regulating RANKL / OPG ratio.Chem. Biol. Drug Des.2022100331331910.1111/cbdd.1410135708158
     [Google Scholar]
  101. LiuY. ZhouC. TanJ. WuT. PanC. LiuJ. ChengX. Ganoderic acid A slows osteoarthritis progression by attenuating endoplasmic reticulum stress and blocking NF‐Kb pathway.Chem. Biol. Drug Des.20241031e1438210.1111/cbdd.1438237984927
     [Google Scholar]
  102. ImD.S. Pro-Resolving effect of ginsenosides as an anti-inflammatory mechanism of Panax ginseng.Biomolecules202010344410.3390/biom1003044432183094
     [Google Scholar]
  103. HossainM.A. AlamM.J. KimB. KangC.W. KimJ.H. Ginsenoside-Rb1 prevents bone cartilage destruction through down-regulation of p-Akt, p-P38, and p-P65 signaling in rabbit.Phytomedicine202210015403910.1016/j.phymed.2022.15403935344713
     [Google Scholar]
  104. GuoY. TianT. YangS. CaiY. Ginsenoside Rg1/ADSCs supplemented with hyaluronic acid as the matrix improves rabbit temporomandibular joint osteoarthrosis.Biotechnol. Genet. Eng. Rev.202340112210.1080/02648725.2023.218357536892223
     [Google Scholar]
  105. ZhaoX. CaoX. FuW. YuP. LiY. YuX. XuH. Protective effect of Ginsenoside Rc on the complete Freund’s adjuvant-induced rheumatoid arthritis in rats by attenuation of inflammatory mediators through inhibition NF-κB pathway.J. Funct. Foods20229510513610.1016/j.jff.2022.105136
     [Google Scholar]
  106. TianY. FengX. ZhouZ. QinS. ChenS. ZhaoJ. HouJ. LiuD. Ginsenoside Compound K Ameliorates osteoarthritis by inhibiting the chondrocyte endoplasmic reticulum stress-mediated IRE1α-TXNIP-NLRP3 axis and pyroptosis.J. Agric. Food Chem.20237131499150910.1021/acs.jafc.2c0613436630614
     [Google Scholar]
  107. LiangY. ChenB. LiangD. QuanX. GuR. MengZ. GanH. WuZ. SunY. LiuS. DouG. Pharmacological effects of astragaloside IV: A review.Molecules20232816611810.3390/molecules2816611837630371
     [Google Scholar]
  108. XuH. Jing-BoW. ChenY.P. HuangW. WeiZ.B. AstragalosideI.V. astragaloside IV protects against IL-1β-induced chondrocyte damage via activating autophagy.Curr. Mol. Med.202424111382138910.2174/011566524024915423101608011537855351
     [Google Scholar]
  109. YangK. XieQ. TangT. ZhaoN. LiangJ. ShenY. LiZ. LiuB. ChenJ. ChengW. BaiX. ZhangP. LiuQ. SongB. HuC. LiuL. WangY. Astragaloside IV as a novel CXCR4 antagonist alleviates osteoarthritis in the knee of monosodium iodoacetate-induced rats.Phytomedicine202310815450610.1016/j.phymed.2022.15450636403512
     [Google Scholar]
  110. CuiX. WangJ. FanC. JiangH. LiW. Astragalosides inhibit proliferation of fibroblast‐like synoviocytes in experimental arthritis by modulating LncRNA S56464. 1/ miR ‐152‐3p/Wnt1 signaling axis.Int. J. Rheum. Dis.20232681547155610.1111/1756‑185X.1478237317788
     [Google Scholar]
  111. JiangH. FanC. LuY. CuiX. LiuJ. Astragaloside regulates lncRNA LOC100912373 and the miR 17 5p/PDK1 axis to inhibit the proliferation of fibroblast like synoviocytes in rats with rheumatoid arthritis.Int. J. Mol. Med.202148113010.3892/ijmm.2021.496334013364
     [Google Scholar]
  112. XieW. QiS. DouL. WangL. WangX. BiR. LiN. ZhangY. Achyranthoside D attenuates chondrocyte loss and inflammation in osteoarthritis via targeted regulation of Wnt3a.Phytomedicine202311115466310.1016/j.phymed.2023.15466336657317
     [Google Scholar]
  113. MengM. YueZ. ChangL. LiuY. HuJ. SongZ. TangZ. ZhouR. WangC. Anti-rheumatoid arthritic effects of paris saponin vii in human rheumatoid arthritis fibroblast-like synoviocytes and adjuvant-induced arthritis in rats.Front. Pharmacol.20211268369810.3389/fphar.2021.68369834122110
     [Google Scholar]
  114. LiP. HuangY. WangJ. ZengJ. LiL. Platycodin D relieves rheumatoid arthritis by promoting apoptosis of mitochondria to inhibit activation of hedgehog pathway.Autoimmunity2023561220505310.1080/08916934.2023.220505337138547
     [Google Scholar]
  115. GuoC. YueY. WangB. ChenS. LiD. ZhenF. LiuL. ZhuH. XieM. Anemoside B4 alleviates arthritis pain via suppressing ferroptosis‐mediated inflammation.J. Cell. Mol. Med.2024284e1813610.1111/jcmm.1813638334255
     [Google Scholar]
  116. Kun-Liu WangJ.Y. ZhangL. PanY.Y. ChenX.Y. YuanY. Effects of betulinic acid on synovial inflammation in rats with collagen-induced arthritis.Int. J. Immunopathol. Pharmacol.202034205873842094507810.1177/205873842094507832718263
     [Google Scholar]
  117. LiuB. WuY. LiangT. ZhouY. ChenG. HeJ. JiC. LiuP. ZhangC. LinJ. ShiK. LuoZ. LiuN. SuX. Betulinic acid attenuates osteoarthritis via limiting nlrp3 inflammasome activation to decrease interleukin-1β maturation and secretion.Mediators Inflamm.20232023112210.1155/2023/370642137789884
     [Google Scholar]
  118. LiuM. GuoJ. ZhaoJ. LiH. FengX. LiuH. ZhangH. JiaX. WeiR. LiF. ChenC. HouM. LvN. XuH. Activation of NRF2 by celastrol increases antioxidant functions and prevents the progression of osteoarthritis in mice.Chin. J. Nat. Med.202422213714510.1016/S1875‑5364(24)60586‑838342566
     [Google Scholar]
  119. AnchiP. ChilveryS. TekalkarS. bolla, L.; Rao Gajula, S.N.; Sonti, R.; Godugu, C. Nimbolide loaded sustained release microparticles as single-dose formulations for effective management of arthritis.J. Drug Deliv. Sci. Technol.20227510363810.1016/j.jddst.2022.103638
     [Google Scholar]
  120. WangM. HuangJ. FanH. HeD. ZhaoS. ShuY. LiH. LiuL. LuS. XiaoC. LiuY. Treatment of rheumatoid arthritis using combination of methotrexate and tripterygium glycosides Tablets—A quantitative plasma pharmacochemical and pseudotargeted metabolomic approach.Front. Pharmacol.20189105110.3389/fphar.2018.0105130356765
     [Google Scholar]
  121. BanjiD. BanjiO.J.F. RashidaS. AlshahraniS. AlqahtaniS.S. Bioavailability, anti-inflammatory and anti-arthritic effect of Acetyl Keto Boswellic acid and its combination with methotrexate in an arthritic animal model.J. Ethnopharmacol.202229211520010.1016/j.jep.2022.11520035306043
     [Google Scholar]
  122. WangX. ZuY. HuangL. YuJ. ZhaoH. WenC. ChenZ. XuZ. Treatment of rheumatoid arthritis with combination of methotrexate and Tripterygium wilfordii: A meta-analysis.Life Sci.2017171455010.1016/j.lfs.2017.01.00428088452
     [Google Scholar]
  123. SrisaisapM. BoonsermP. Anticancer efficacy of biosynthesized silver nanoparticles loaded with recombinant truncated parasporin-2 protein.Sci. Rep.20241411554410.1038/s41598‑024‑66650‑538969695
     [Google Scholar]
  124. ChenZ. WangA. QinY. ChenX. FengX. HeG. ZhuX. XiaoY. YuX. ZhongT. ZhangK. Preparation of a thermosensitive and antibacterial in situ gel using poloxamer-quaternized chitosan for sustained ocular delivery of Levofloxacin hydrochloride.Int. J. Biol. Macromol.2024283Pt 113747910.1016/j.ijbiomac.2024.13747939537073
     [Google Scholar]
  125. LiL. HeD. GuoQ. ZhangZ. RuD. WangL. GongK. LiuF. DuanY. LiH. Exosome-liposome hybrid nanoparticle codelivery of TP and miR497 conspicuously overcomes chemoresistant ovarian cancer.J. Nanobiotechnology20222015010.1186/s12951‑022‑01264‑535078498
     [Google Scholar]
  126. FaustinoC. DuarteN. PinheiroL. Triterpenes drug delivery systems, a modern approach for arthritis targeted therapy.Pharmaceuticals20231715410.3390/ph1701005438256888
     [Google Scholar]
  127. CanterP.H. LeeH.S. ErnstE. A systematic review of randomised clinical trials of Tripterygium wilfordii for rheumatoid arthritis.Phytomedicine200613537137710.1016/j.phymed.2006.01.01016487688
     [Google Scholar]
  128. ZhengW. MeiY. ChenC. CaiL. ChenH. The effectiveness and safety of Tripterygium wilfordii glycosides combined with disease‐modifying anti‐rheumatic drugs in the treatment of rheumatoid arthritis: A systematic review and meta‐analysis of 40 randomized controlled trials.Phytother. Res.20213562902292410.1002/ptr.699633368709
     [Google Scholar]
  129. ZhouY.Y. XiaX. PengW.K. WangQ.H. PengJ.H. LiY. WuJ.X. ZhangJ.Y. ZhaoY. ChenX.M. HuangR.Y. JakobssonP.J. WenZ.H. HuangQ.C. The effectiveness and safety of tripterygium wilfordii hook. f extracts in rheumatoid arthritis: A Systematic Review and Meta-Analysis.Front. Pharmacol.2018935610.3389/fphar.2018.0035629713281
     [Google Scholar]
  130. YuG. XiangW. ZhangT. ZengL. YangK. LiJ. Effectiveness of Boswellia and Boswellia extract for osteoarthritis patients: a systematic review and meta-analysis.BMC Comp. Med. Ther.202020122510.1186/s12906‑020‑02985‑632680575
     [Google Scholar]
/content/journals/mrmc/10.2174/0113895575389522250825063702
Loading
Triterpenoid Compounds and their Derivatives: Emerging Pharmacological Agents for Arthritis Treatment
Mini Rev Med Chem 25, 1127 (2025); https://doi.org/10.2174/0113895575389522250825063702
/content/journals/mrmc/10.2174/0113895575389522250825063702
/content/journals/mrmc/10.2174/0113895575389522250825063702
Loading

Data & Media loading...


  • Article Type:     Review Article
Keyword(s): AIDS; inflammation; natural products; osteoarthritis; rheumatoid arthritis; Triterpenoids

Most Cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test